Comparison of two doses of imatinib for the treatment of unresectable or metastatic gastrointestinal stromal tumors: a meta-analysis of 1,640 patients - Gastrointestinal Stromal Tumor Meta-Analysis Group (MetaGIST) (J Clin Oncol, 2010)